Table 1.
Editorial decision | All Submissions | STROBE | ARRIVE | MIQE | CONSORT | REMARK | PRISMA | STARD | MOOSE | BRISQ | STREGA | CHEERS |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All, no. (%) | 2209 (100) | 531 (24.0) | 150 (6.8) | 54 (2.4) | 96 (4.3) | 140 (6.3) | 133 (6.0) | 65 (2.9) | 26 (1.2) | 34 (1.5) | 23 (1.0) | 4 (0.2) |
Sent to peer review | 396 (17.9) | 86 (3.9) | 28 (1.3) | 5 (0.2) | 23 (1.0) | 24 (1.1) | 25 (1.1) | 10 (0.5) | 7 (0.3) | 4 (0.2) | 7 (0.3) | 0 (0.0) |
Rejected after peer review | 255 (11.5) | 36 (1.6) | 14 (0.6) | 3 (0.1) | 7 (0.3) | 12 (0.5) | 16 (0.7) | 5 (0.2) | 1 (0.0) | 3 (0.1) | 4 (0.2) | 0 (0.0) |
Not rejected after peer review | 141 (6.4) | 50 (2.3) | 14 (0.6) | 2 (0.1) | 16 (0.7) | 12 (0.5) | 9 (0.4) | 5 (0.2) | 6 (0.3) | 1 (0.0) | 3 (0.1) | 0 (0.0) |
Not sent to peer review | 1813 (82.1) | 445 (20.1) | 122 (5.5) | 49 (2.2) | 73 (3.3) | 116 (5.3) | 108 (4.9) | 55 (2.5) | 19 (0.9) | 30 (1.4) | 16 (0.7) | 4 (0.2) |
Reject without review | 98 (4.4) | 22 (1.0) | 1 (0.0) | 1 (0.0) | 2 (0.1) | 2 (0.1) | 8 (0.4) | 2 (0.1) | 1 (0.0) | 2 (0.1) | 0 (0.0) | 2 (0.1) |
Priority reject | 1715 (77.6) | 423 (19.1) | 121 (5.5) | 48 (2.2) | 71 (3.2) | 114 (5.2) | 100 (4.5) | 53 (2.4) | 18 (0.8) | 28 (1.3) | 16 (0.7) | 2 (0.1) |
STROBE Strengthening-Reporting of Observational-Studies in Epidemiology, ARRIVE Animal Research: Reporting In Vivo Experiments, MIQE Minimum Information for Publication of Quantitative Real-Time PCR Experiments, CONSORT Consolidated Standards of Reporting Trials, REMARK Reporting recommendations for tumour Marker prognostic studies, PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analyses, STARD studies of diagnostic accuracy, MOOSE Meta-analyses of Observational Studies, BRISQ Biospecimen reporting for improved study quality, STREGA Strengthening the Reporting of Genetic Association Studies , an extension to STROBE; and Consolidated Health Economic Evaluation Reporting Standards (CHEERS)